Highlights and Quick Summary
- Operating Cash Flow Margin for the quarter ending June 30, 2023 was -33.86% (a -69.62% decrease compared to previous quarter)
- Year-over-year quarterly Operating Cash Flow Margin increased by 9.83%
- Annual Operating Cash Flow Margin for 2022 was -3.04% (a -116.97% decrease from previous year)
- Annual Operating Cash Flow Margin for 2021 was 17.91% (a -48.03% decrease from previous year)
- Annual Operating Cash Flow Margin for 2020 was 34.46% (a 102.71% increase from previous year)
- Twelve month Operating Cash Flow Margin ending June 30, 2023 was -26.04% (a 40.91% increase compared to previous quarter)
- Twelve month trailing Operating Cash Flow Margin decreased by -295.06% year-over-year
Trailing Operating Cash Flow Margin for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -26.04% | -18.48% | -3.04% | 13.35% |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating Cash Flow Margin of Emergent Biosolutions Inc.
Most recent Operating Cash Flow Marginof EBS including historical data for past 10 years.Interactive Chart of Operating Cash Flow Margin of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Operating Cash Flow Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -33.86% | -111.45% | – | – | – |
| 2022 | 28.06% | -30.83% | -6.43% | -12.13% | -3.04% |
| 2021 | 45.49% | 5.08% | -7.47% | 1.49% | 17.91% |
| 2020 | 42.04% | 27.31% | 32.4% | 30.03% | 34.46% |
| 2019 | 33.88% | -0.99% | -14.72% | 54.98% | 17.0% |
| 2018 | -61.23% | 100.23% | 15.71% | -0.85% | 5.34% |
| 2017 | 39.98% | 23.38% | 53.59% | 35.66% | 37.1% |
| 2016 | -8.34% | 18.95% | -2.19% | 40.96% | 11.17% |
| 2015 | 0.8% | 66.14% | 1.98% | -103.52% | 8.69% |
| 2014 | 50.65% | 57.21% | 9.81% | -54.27% | 27.77% |
| 2013 | 8.81% | 67.48% | 39.82% | -10.73% | 31.01% |
| 2012 | -41.24% | 69.8% | – | – | 14.06% |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic